Skip to main content
. 2021 May 13;10(10):2105. doi: 10.3390/jcm10102105

Table 3.

Characteristic of total patients treated with LT4.

TOT
F-T Pregnancy (n = 134)
TOT
Miscarriage (n = 28)
TOT
No Pregnancy (n = 65)
LT4 t0 (μg/die) 42.16 ± 12.42 42.86 ± 13.36 (p = 0.79 NS) 42.31 ± 11.63 (p = 0.93NS)
LT4t1 (μg/die) 44.22 ± 12.61 46.43 ± 17.63 (p = 0.43 NS) 43.08 ± 12.11 (p = 0.54 NS)
LT4t2 (μg/die) 46.83 ± 14.52 54.46 ± 19.31 (p = 0.0184) /
Dose Incr1 2.05 ± 6.89 3.57 ± 13.11 (p = 0.37 NS) 0.77 ± 4.35 (p = 0.17 NS)
Dose Incr 2 2.61 ± 8.82 8.04 ± 13.70 (p = 0.0086) /
Dose Incr Tot 4.66 ± 10.25 11.61 ± 15.93 (p = 0.0039) /